Shyra Gardai

Company: EpiBiologics

Job title: Chief Scientific Officer

Seminars:

Harnessing Innovative Platforms, Molecular & Cellular Assay Development & Screening Techniques to Explore Novel Protein Degradation Targets 11:30 am

Protein degradation has immense potential to drug the ‘undruggable’ – by eliminating disease causing proteins previously thought to be not addressable by classical therapeutic approaches. Extracellular proteins compose approximately 40% of the proteome, creating vast untapped potential until now…  Attend this Workshop to: Uncover the vast potential in unlocking extracellular targets for degradation via alternative…Read more

day: Pre-Conference Workshop Day